How much information is enough? It appears today that there's never enough to go around. Hopefully as the field of personalized medicine grows we will have more answers in the ability to predict and understand more about how different drugs work and what the projected outcomes will be with all. BD
The differences between the drugs aren't just in the mode of administration. Primary care physicians are the main prescribers of Januvia and they tend to prescribe it early in the course of the disease, whereas Byetta is typically more of a specialist-prescribed medication used in more advanced diabetes cases. For its part, Merck responded quickly with some of its own study critiques. Dr. Barry Goldstein, vice president of clinical research at Merck told Forbes.com that the study neglected to note that Januvia has less severe side effects than Byetta and works steadily over a 24-hour period. "The study is really looking at the peak of when Byetta is in the body after it is injected," he said.
0 comments :
Post a Comment